Table 5:
Comparison of Studies of Lifestyle Intervention vs
Pharmacological Agents
Study |
Intervention |
N |
Duration (yrs.) |
Risk Reduction (%) |
Follow up time (yrs.) |
Follow up risk
reduction (%) |
CVD events/Total
mortality reduction (%) |
|
Lifestyle
Intervention studies |
||||||||
|
Diet Exercise Diet
and Exercise Control |
130 141 126 133 |
6 |
31 46 42 |
20 |
43 |
2/4 |
|
|
Diet
and Physical Activity Control |
265 257 |
3.2 |
58 |
7 |
43 |
4/43 |
|
DPP
US [11]
|
Diet
and Physical activity Metformin Placebo |
1079 1073 1082 |
2.8 |
58 31 |
10 |
34 |
No
Data |
|
Pharmacological
Intervention studies |
||||||||
DPP
US [11] |
Metformin |
1073 |
2.8 |
31 |
10 |
18 |
No
Data |
|
TRIPOD
[23] |
Troglitazone |
236 |
2.5 |
55 |
|
|
|
|
Acarbose |
1368 |
3.2 |
36 |
NA |
NA |
49 |
||
DREAM
[14]
|
Rosiglitazone |
5269 |
3.0 |
60 |
NA |
NA |
No
Data |
|
XENDOS
[24] |
Orlistat |
3305 |
4.0 |
37 |
NA |
NA |
No
Data |
|